AGC launches takeover bid for Italian biotech firm Molmed
13:25 PM | March 17, 2020 | Natasha Alperowicz
Offer subject to 66.7% acceptance and unexpected impacts of the COVID-19 outbreak.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.